Oct 7, 2010 | Laboratory News, Laboratory Pathology, News From Dark Daily
Lab Manager Training will take place in Baltimore, San Francisco, Chicago, and Miami
Very shortly, the lack of experienced and competent laboratory managers will become the next intractable staffing problem for the nation’s clinical laboratories and pathology groups. Most medical laboratories—already struggling to find adequate numbers of medical technologists (MT) and clinical laboratory scientists (CLS)—will find themselves with an even more acute shortage of skilled managers at every level, from bench supervision to senior laboratory leadership.
Clinical lab managers about to retire in waves
Simply said, the nation’s laboratory leaders are about to experience a demographic time bomb that will rapidly decimate all levels of lab managers in their clinical pathology laboratories. Few medical laboratory organizations are prepared to respond effectively to the predicted rapid turnover among their most experienced and skilled lab managers.
Of course, the demographic time bomb refers to the coming tidal wave of baby boomer retirements. As a reminder, on January 1, 2011—just 85 days away—the oldest baby boomer turns 65 and becomes eligible for social security and Medicare benefits!
(more…)
Sep 9, 2010 | Laboratory Pathology, Management & Operations
Special clinical laboratory manager training to take place in four cities this fall
Predictions are that clinical laboratories and pathology groups across the nation will face a growing and serious shortage of skilled managers during the next 24 months. There are two primary reasons why this acute shortage of capable lab managers is soon to develop.
First, the oldest baby boomers turn 65 in January and the long-awaited wave of retirements will begin. This means the most experienced staff members in the medical laboratory—managers at the bench level, the section, and the department—will vacate those positions of responsibility. As these managers depart, the lab loses their decades of experience, along with their invaluable organizational knowledge.
(more…)
Sep 6, 2010 | Laboratory Management and Operations, Laboratory News, Laboratory Pathology
New resource library on clinical pathology laboratory management can be accessed via Web
There is a new resource library for clinical laboratory managers and pathologists that contains White Papers on contemporary topics involving clinical laboratory management, pathology administration, and the medical laboratory testing marketplace. This White Paper library is hosted at www.DarkDaily.com/white-papers and is a useful new information resource for the clinical laboratory profession.
The White Paper resource library is another example of how the Internet and Web 2.0 creates new educational opportunities for medical laboratory professionals and pathologists. The White Papers on clinical laboratory and pathology topics can be accessed 24/7 from anywhere in the world. Each White Paper can be downloaded immediately as a PDF.
(more…)
Sep 25, 2009 | Laboratory Management and Operations, Laboratory News, Laboratory Pathology, Management & Operations
Unproductive workplace dynamics retard performance improvement efforts
Some quality experts are recognizing that the true root causes of non-conforming events in clinical laboratories and pathology groups are not flaws in individual work processes. Rather, they argue the true root causes of defects are actually embedded organizational values and beliefs which management uses to justify and reinforce the way it organizes and operates the laboratory.
This perspective on management values as the true root cause of defects was articulated in 2003 in a paper titled the “Seven Deadly Sins of Quality Management.” It was published in “Quality Progress” by John Dew, Director of Continuous Quality Improvement at the University of Alabama.
(more…)
Aug 26, 2009 | Laboratory Management and Operations, Laboratory News, Laboratory Pathology
Deal with Abbott Labs gives Neogenomics access to proprietary probes
Diagnostic testing for melanoma generates a substantial number of tests annually, making it a lucrative target for any clinical laboratory or biotech company that can develop an assay that utilizes state-of-the-art molecular technologies and offers improved detection and accuracy.
Once company working to develop such a new diagnostic test for melanoma is Neogenomics, Inc. (OTC:NGNM.OB). It announced an agreement with Abbott Laboratories, Inc. (NYSE:ABT). on July 24, 2009. Abbott Laboratories will supply Neogenomics with proprietary probes to develop and commercialize its own FISH-based (Fluorescence in situ hyrbridization) test for melanoma.
(more…)
